# A third of Quebecers are exposed to cannabis advertising, according to a study > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-advertising-exposure-quebec-study/ > **Published:** 2026-04-15T11:12:30-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:21:37-04:00 > **Clinical Summary:** Explore cannabis advertising exposure among Quebecers and its influence on patient perceptions and clinical conversations in this recent study. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic [Public Health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/)Patient EducationCannabis Policy[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Health Communication Why This Matters Cannabis advertising exposure directly influences patient perceptions, usage patterns, and clinical conversations. Understanding advertising reach helps clinicians anticipate patient knowledge sources and potential misinformation when providing cannabis-related medical guidance. Clinical Summary A study found that one-third of Quebec residents report exposure to cannabis advertising, though specific exposure mechanisms, messaging content, and demographic patterns are not detailed in the available summary. This represents significant population-level exposure to commercial cannabis messaging in a regulated market environment. The clinical implications depend heavily on advertising content quality, accuracy of health claims, and whether messaging aligns with evidence-based medical guidance. Dr. Caplan’s Take “When a third of patients are seeing cannabis ads, I’m seeing the downstream effects in my clinic — patients arrive with commercial messaging mixed with medical questions, and I spend significant time separating marketing from medicine.” Clinical Perspective 🧠 Clinicians should proactively ask patients about their information sources when discussing cannabis therapeutically. Consider that commercial advertising may shape patient expectations about effects, dosing, and medical applications in ways that require clinical correction or clarification during medical consultations. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20A%20third%20of%20Quebecers%20are%20exposed%20to%20cannabis%20advertising%2C%20according%20to%20a%20study%20%40drcaplan&url=https%3A//montreal.citynews.ca/2026/04/15/quebecers-cannabis-advertising-study/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//montreal.citynews.ca/2026/04/15/quebecers-cannabis-advertising-study/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20A%20third%20of%20Quebecers%20are%20exposed%20to%20cannabis%20advertising%2C%20according%20to%20a%20study%20--%20via%20%40drcaplan.bsky.social%20https%3A//montreal.citynews.ca/2026/04/15/quebecers-cannabis-advertising-study/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://montreal.citynews.ca/2026/04/15/quebecers-cannabis-advertising-study/](https://montreal.citynews.ca/2026/04/15/quebecers-cannabis-advertising-study/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What topics does this cannabis news article cover?](#What_topics_does_this_cannabis_news_article_cover) - [Who is the source of this cannabis news?](#Who_is_the_source_of_this_cannabis_news) - [Why is this news marked as “New”?](#Why_is_this_news_marked_as_8220New8221) - [How should healthcare providers use this high-relevance cannabis information?](#How_should_healthcare_providers_use_this_high-relevance_cannabis_information) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned a CED Clinical Relevance rating of #80, which indicates “High Clinical Relevance.” This means the content has strong evidence or policy relevance with direct clinical implications for healthcare providers. #### What topics does this cannabis news article cover? The article covers multiple important areas including [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/), patient education, cannabis policy, and medical cannabis. These categories suggest the news has broad implications across different aspects of cannabis healthcare and regulation. #### Who is the source of this cannabis news? This news comes from CED Clinic, which appears to be a cannabis-focused medical organization. The source specializes in cannabis-related clinical information and policy updates. #### Why is this news marked as “New”? The article is tagged as “New” to indicate it contains recently published or updated information. This helps healthcare providers and patients stay current with the latest developments in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and policy. #### How should healthcare providers use this high-relevance cannabis information? Given its high clinical relevance rating, healthcare providers should consider this information when making clinical decisions involving cannabis treatments. The content likely contains evidence-based findings that can directly impact [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and treatment protocols. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabinoids for sleep: Could cannabinol be the best option? – Study Summary](https://cedclinic.com/cannabinoid-sleep-research-2026-cannabinol-insights/) Review the latest findings on cannabinol's potential benefits for sleep and how it compares to other cannabinoids. [Read Study Summary](https://cedclinic.com/cannabinoid-sleep-research-2026-cannabinol-insights/) [UW study: Gap in doctors' knowledge on cannabis | FOX 13 Seattle](https://cedclinic.com/physician-training-cannabis-knowledge-gap-uw-study/) Explore research highlighting knowledge gaps among healthcare providers regarding cannabis and its clinical applications. [Explore Research](https://cedclinic.com/physician-training-cannabis-knowledge-gap-uw-study/) [Make false memories feel real. A 2026 study found that acute cannabis intoxication … – Instagram](https://cedclinic.com/acute-cannabis-intoxication-false-memories-2026-study/) Discover how acute cannabis intoxication can affect memory formation and perception based on recent research. [Learn More](https://cedclinic.com/acute-cannabis-intoxication-false-memories-2026-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).